Н Д Хорошко

1.2k citations
13 papers · 883 indexed · h-index 8
Topics
Chronic Myeloid Leukemia Treatments (9 papers)Chronic Lymphocytic Leukemia Research (8 papers)Eosinophilic Disorders and Syndromes (6 papers)

In The Last Decade

Н Д Хорошко

12 papers receiving 840 citations

Peers

Н Д Хорошко
Comparison fields: 5 of 53
  • Hematology 767
  • Genetics 651
  • Rheumatology 511
  • Oncology 126
  • Public Health, Environmental and Occupational Health 77
Replace Jorge Milone with:
Jorge Milone Argentina
Nadine Besson United States
Manuel Ayala Mexico
Laurie Letvak United States
Marianne Rosamilia United States
Jenny Shan United States
Marie‐Pierre Noël France
D-W Kim Australia
Agnès Guerci‐Bresler France
Bruno Villemagne France
Н Д Хорошко relative to Jorge Milone Argentina Jorge Milone's profile →
Citations per field
00.5×1.5×
Jorge Milone · 1×
Citations per year

Countries citing papers authored by Н Д Хорошко

Since Specialization
Citations

This map shows the geographic impact of Н Д Хорошко's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Н Д Хорошко with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Н Д Хорошко more than expected).

Fields of papers citing papers by Н Д Хорошко

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Н Д Хорошко. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Н Д Хорошко. The network helps show where Н Д Хорошко may publish in the future.

Co-authorship network of co-authors of Н Д Хорошко

This figure shows the co-authorship network connecting the top 25 collaborators of Н Д Хорошко. A scholar is included among the top collaborators of Н Д Хорошко based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Н Д Хорошко. Н Д Хорошко is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 127
2
[Dasatinib treatment of imatinib-resistant and imatinib-intolerant patients with chronic myeloid leukemia in a chronic phase].
0
3 11
4 371
5 37
6 277
7 5
8
[Invasive aspergillosis in immunocompromised patients].
3
9 6
10 16
11 21
12 7
13 2

About Н Д Хорошко

Н Д Хорошко is a scholar working on Hematology, Genetics and Rheumatology, having authored 13 papers that have together received 883 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (9 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Eosinophilic Disorders and Syndromes (6 papers). The work is most often cited by research in Hematology (767 citations), Genetics (651 citations) and Rheumatology (511 citations). Н Д Хорошко has collaborated with scholars based in Russia, United States and Germany. Frequent co-authors include Timothy P. Hughes, Neil P. Shah, Pedro Enrique Dorlhiac‐Llacer, Hagop M. Kantarjian, Dong‐Wook Kim, H. Jean Khoury, Ricardo Pasqüini, Jerald P. Radich, А К Голенков and Eric Bleickardt. Their work appears in journals such as Journal of Clinical Oncology, Blood and Advances in experimental medicine and biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026